Compare NTB & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTB | TNDM |
|---|---|---|
| Founded | 1858 | 2006 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.4B |
| IPO Year | 2016 | 2013 |
| Metric | NTB | TNDM |
|---|---|---|
| Price | $55.69 | $20.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 19 |
| Target Price | ★ $53.75 | $28.00 |
| AVG Volume (30 Days) | 109.0K | ★ 1.5M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.55% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,014,736,000.00 |
| Revenue This Year | $0.84 | $8.11 |
| Revenue Next Year | $4.16 | $11.85 |
| P/E Ratio | $9.64 | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $39.35 | $10.00 |
| 52 Week High | $57.84 | $29.65 |
| Indicator | NTB | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 61.01 | 47.04 |
| Support Level | $51.23 | $19.70 |
| Resistance Level | $56.23 | $21.68 |
| Average True Range (ATR) | 0.91 | 1.18 |
| MACD | -0.06 | 0.14 |
| Stochastic Oscillator | 52.91 | 55.97 |
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.